As a leading innovator in healthcare, Johnson & Johnson in Switzerland is in a unique position to help shape the future of healthcare.
From the acquisition of Cilag AG in 1959 to other significant acquisitions such as Crucell, Synthes GmbH, and Actelion Pharmaceuticals, we have always been committed to improving health through innovation. This has led us to the influential foothold we have in Switzerland today.
From research and development to production and distribution, the entire value chain of our MedTech and Innovative Medicine sectors is represented in Switzerland at several locations with over 5,000 employees.
We have had a strong partnership with Special Olympics Switzerland since 2016. Together, we are committed to a healthy future. For everyone.
Community Impact & Apprenticeship Program Lead at
Johnson & Johnson